Steroid resistance and rebound phenomena in patients with COVID-19()

BACKGROUND: In patients with coronavirus disease (COVID-19) pneumonia, corticosteroids reduce progression to respiratory failure and death. Some patients, however, remain unresponsive to this treatment, or experience a rebound after termination. METHODS: This retrospective cohort study included COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Ryosuke, Ro, Shosei, Tomishima, Yutaka, Nishimura, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196332/
https://www.ncbi.nlm.nih.gov/pubmed/34154977
http://dx.doi.org/10.1016/j.resinv.2021.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196332/
https://www.ncbi.nlm.nih.gov/pubmed/34154977
http://dx.doi.org/10.1016/j.resinv.2021.05.007

Ejemplares similares